Código QR (código de barras bidimensional)

Splenectomy following JAK1/JAK2 inhibitor therapy in patients with myelofibrosis undergoing allogeneic stem cell transplantation

Background: Allogeneic hematopoietic stem cell transplantation (alloHSCT) is the only treatment option with curative potential in patients with myelofibrosis (MF). The aim of our study was to evaluate the safety of splenectomy before alloHSCT in MF patients who failed to achieve significant spleen r...

ver descrição completa

Na minha lista:
Principais autores: Maria Vladimirovna Barabanshikova, Igor Nikolaevich Zubarovsky, Vjacheslav Mikhailovich Savrasov, Andrey Jurjevich Korolkov, Vadim Valentinovich Baykov, Anna Vjacheslavovna Botina, Julia Jurjevna Vlasova, Ivan Sergeevich Moiseev, Elena Igorevna Darskaya, Elena Vladislavovna Morozova, Boris Vladimirovich Afanasyev
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Medknow Publications 2019-07-01
coleção:Hematology/Oncology and Stem Cell Therapy
Assuntos:
allogeneic hematopoietic stem cell transplantation
myelofibrosis
ruxolitinib
splenectomy
Acesso em linha:https://journals.lww.com/10.1016/j.hemonc.2019.03.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados